BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+9.39%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$7.44B
AUM Growth
+$202M
(+2.8%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
10.46%
Holding
1,456
New
149
Increased
274
Reduced
293
Closed
153
Top Buys
| 1 |
Elevance Health
ELV
|
$52.3M |
| 2 |
Fortive
FTV
|
$46M |
| 3 |
US Bancorp
USB
|
$45.8M |
| 4 |
Campbell Soup
CPB
|
$45.3M |
| 5 |
Brown-Forman Class B
BF.B
|
$45.3M |
Top Sells
| 1 |
Travelers Companies
TRV
|
$64.6M |
| 2 |
Best Buy
BBY
|
$60.2M |
| 3 |
Tyson Foods
TSN
|
$54.1M |
| 4 |
Union Pacific
UNP
|
$47.5M |
| 5 |
Church & Dwight Co
CHD
|
$46M |
Sector Composition
| 1 | Financials | 25.43% |
| 2 | Industrials | 11.21% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Technology | 10.38% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Incyte
INCY
$16.9B
| – | – |
-58,200
| Closed | -$4.32M |
|
1377
Inseego
INSG
$199M
| – | – |
-2,190
| Closed | -$105K |
|
1378
Iridium Communications
IRDM
$2.67B
| – | – |
-664,950
| Closed | -$14.2M |
|
1379
Investar Holding Corp
ISTR
$227M
| – | – |
-21,800
| Closed | -$519K |
|
|
JNPR
1380
DELISTED
Juniper Networks
JNPR
| – | – |
-371,900
| Closed | -$9.21M |
|
1381
Kadant
KAI
$3.85B
| – | – |
-6,600
| Closed | -$579K |
|
1382
KB Home
KBH
$4.63B
| – | – |
-310,600
| Closed | -$10.6M |
|
|
KNDI
1383
Kandi Technologies Group
KNDI
$114M
| – | – |
-70,100
| Closed | -$327K |
|
1384
Loews
L
$20B
| – | – |
-832,790
| Closed | -$42.9M |
|
1385
El Pollo Loco
LOCO
$314M
| – | – |
-80,500
| Closed | -$882K |
|
1386
Leap Therapeutics
LPTX
$11.7M
| – | – |
-3,630
| Closed | -$42K |
|
1387
Lam Research
LRCX
$130B
| – | – |
-112,000
| Closed | -$2.59M |
|
1388
Larimar Therapeutics
LRMR
$337M
| – | – |
-3,675
| Closed | -$33K |
|
1389
Moelis & Co
MC
$5.24B
| – | – |
-7,100
| Closed | -$233K |
|
1390
Seres Therapeutics
MCRB
$169M
| – | – |
-7,630
| Closed | -$612K |
|
1391
Medifast
MED
$149M
| – | – |
-3,500
| Closed | -$363K |
|
1392
McCormick & Company Non-Voting
MKC
$19B
| – | – |
-428,900
| Closed | -$33.5M |
|
1393
Marsh & McLennan
MMC
$100B
| – | – |
-18,200
| Closed | -$1.82M |
|
|
MREO
1394
Mereo BioPharma
MREO
$282M
| – | – |
-15,961
| Closed | -$46K |
|
1395
Myomo
MYO
$37.7M
| – | – |
-1,667
| Closed | -$31K |
|
1396
NMI Holdings
NMIH
$3.1B
| – | – |
-65,700
| Closed | -$1.73M |
|
1397
Insperity
NSP
$2.03B
| – | – |
-38,600
| Closed | -$3.81M |
|
1398
Northwest Bancshares
NWBI
$1.86B
| – | – |
-351,000
| Closed | -$5.75M |
|
1399
Option Care Health
OPCH
$4.72B
| – | – |
-92,175
| Closed | -$1.18M |
|
1400
Prologis
PLD
$105B
| – | – |
-295,000
| Closed | -$25.1M |
|